These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10353877)

  • 1. Protection after two doses of measles vaccine is independent of interval between doses.
    De Serres G; Sciberras J; Naus M; Boulianne N; Duval B; Rochette L
    J Infect Dis; 1999 Jul; 180(1):187-90. PubMed ID: 10353877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outbreak of measles in a highly vaccinated secondary school population.
    Sutcliffe PA; Rea E
    CMAJ; 1996 Nov; 155(10):1407-13. PubMed ID: 8943928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sequence of vaccinations and increased female mortality after high-titre measles vaccine: trials from rural Sudan and Kinshasa.
    Aaby P; Ibrahim SA; Libman MD; Jensen H
    Vaccine; 2006 Apr; 24(15):2764-71. PubMed ID: 16457909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy.
    Yuan L
    CMAJ; 1994 Apr; 150(7):1093-8. PubMed ID: 8137189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of two dose measles vaccination in a community setting.
    Phadke MA; Bhargava I; Dhaigude P; Bagade A; Biniwale MA; Kurlekar SU
    Indian Pediatr; 1998 Aug; 35(8):723-5. PubMed ID: 10216565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
    Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
    Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measles in Poland in 2002].
    Czarkowski MP; Kondej B
    Przegl Epidemiol; 2004; 58(1):21-7. PubMed ID: 15218638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two doses of measles vaccine: are some states in India ready for it?
    John S; Sanghi S; Prasad S; Bose A; George K
    J Trop Pediatr; 2009 Aug; 55(4):253-6. PubMed ID: 18799515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical effectiveness of antimeasles vaccine in Canarias. A case-control study].
    Gago García C; Anía Lafuente BJ; Luque Jiménez M; Pérez-Tabernero MJ
    Rev Clin Esp; 1990 Mar; 186(5):216-20. PubMed ID: 2377773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-specific effect of measles vaccination on overall child mortality in an area of rural India with high vaccination coverage: a population-based case-control study.
    Kabir Z; Long J; Reddaiah VP; Kevany J; Kapoor SK
    Bull World Health Organ; 2003; 81(4):244-50. PubMed ID: 12764490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control study of vaccination history in relation to pertussis risk during an outbreak among school students.
    Khan FN; Lin M; Hinkle CJ; Franklin P; Luther R; Woodruff F; Henson K; Lukenbill M; Gutierrez M; Zhu BP
    Pediatr Infect Dis J; 2006 Dec; 25(12):1132-6. PubMed ID: 17133158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles vaccination during the respiratory virus season and risk of vaccine failure.
    Edmonson MB; Davis JP; Hopfensperger DJ; Berg JL; Payton LA
    Pediatrics; 1996 Nov; 98(5):905-10. PubMed ID: 8909484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measles vaccination with split vaccines and living vaccines (author's transl)].
    Stehr K; Enders-Ruckle G; Spiess H
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1159-64. PubMed ID: 808710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of protection afforded by single measles vaccination and late revaccination schedules.
    Marufu T; Siziya S; Tshimanga M; Murugasampillay S; Mason E
    East Afr Med J; 1997 Dec; 74(12):777-9. PubMed ID: 9557421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles epidemic in the Netherlands, 1999-2000.
    van den Hof S; Conyn-van Spaendonck MA; van Steenbergen JE
    J Infect Dis; 2002 Nov; 186(10):1483-6. PubMed ID: 12404165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles vaccine effectiveness and risk factors for measles in Dhaka, Bangladesh.
    Akramuzzaman SM; Cutts FT; Hossain MJ; Wahedi OK; Nahar N; Islam D; Shaha NC; Mahalanabis D
    Bull World Health Organ; 2002; 80(10):776-82. PubMed ID: 12471397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migration as a risk factor for measles after a mass vaccination campaign, Burkina Faso, 2002.
    Yaméogo KR; Perry RT; Yaméogo A; Kambiré C; Kondé MK; Nshimirimana D; Kezaala R; Hersh BS; Cairns KL; Strebel P
    Int J Epidemiol; 2005 Jun; 34(3):556-64. PubMed ID: 15659463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.